APA

Rosengart T. K., Lee L. Y., Patel S. R., Sanborn T. A., Parikh M., Bergman G. W., Hachamovitch R., Szulc M., Kligfield P. D., Okin P. M., Hahn R. T., Devereux R. B., Post M. R., Hackett N. R., Foster T., Grasso T. M., Lesser M. L., Isom O. W. & Crystal R. G. (19990813). Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. : Circulation.

Chicago

Rosengart T K, Lee L Y, Patel S R, Sanborn T A, Parikh M, Bergman G W, Hachamovitch R, Szulc M, Kligfield P D, Okin P M, Hahn R T, Devereux R B, Post M R, Hackett N R, Foster T, Grasso T M, Lesser M L, Isom O W and Crystal R G. 19990813. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. : Circulation.

Harvard

Rosengart T. K., Lee L. Y., Patel S. R., Sanborn T. A., Parikh M., Bergman G. W., Hachamovitch R., Szulc M., Kligfield P. D., Okin P. M., Hahn R. T., Devereux R. B., Post M. R., Hackett N. R., Foster T., Grasso T. M., Lesser M. L., Isom O. W. and Crystal R. G. (19990813). Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. : Circulation.

MLA

Rosengart T K, Lee L Y, Patel S R, Sanborn T A, Parikh M, Bergman G W, Hachamovitch R, Szulc M, Kligfield P D, Okin P M, Hahn R T, Devereux R B, Post M R, Hackett N R, Foster T, Grasso T M, Lesser M L, Isom O W and Crystal R G. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. : Circulation. 19990813.